Kashaf Waqar, and A. Zainab. “The Tale and Trials of Efgartigimod: A Newly FDA Approved Drug for the Treatment of Myasthenia Gravis”. Journal of the Pakistan Medical Association, vol. 72, no. 11, Oct. 2022, pp. 2366-7, doi:10.47391/JPMA.6388.